Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis

Molecular Carcinogenesis

Volumn 49, Issue 11, 2010, Pages 974-980

  Pande, Mala ^a   Amos, Christopher I ^a,b   Eng, Cathy ^a   Frazier, Marsha L ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cytochrome P 450 CYP1A1; Gene environment interaction; Genetic epistasis; Microsomal epoxide hydrolase

Indexed keywords

CYTOCHROME P450 1A1; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 1; UNCLASSIFIED DRUG; EPHX1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RISK; CIGARETTE SMOKING; COLORECTAL CANCER; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; CASE CONTROL STUDY; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTOR; SMOKING; UNITED STATES;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A1; EPOXIDE HYDROLASES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SMOKING; UNITED STATES;

EID: 78149354468     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20682     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 725-731.
3. Rowley PT. Inherited susceptibility to colorectal cancer. Annu Rev Med 2005; 56: 539-554.
4. de Jong MM, Nolte IM, te Meerman GJ, et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2002; 11: 1332-1352.
5. Gonzalez FJ, Gelboin HV. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 1994; 26: 165-183.
6. Parke DV. The cytochromes P450 and mechanisms of chemical carcinogenesis. Environ Health Perspect 1994; 102: 852-853.
7. Crofts F, Taioli E, Trachman J, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 15: 2961-2963.
8. Omiecinski CJ, Hassett C, Hosagrahara V. Epoxide hydrolase-Polymorphism and role in toxicology. Toxicol Lett 2000; 112-113: 365-370.
9. Pande M, Amos CI, Osterwisch DR, et al. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev 2008; 17: 2393-2401.
10. Pande M, Chen J, Amos CI, Lynch PM, Broaddus R, Frazier ML. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population. Cancer Epidemiol Biomarkers Prev 2007; 16: 1753-1759.
11. Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med 1994; 13: 153-162.
12. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls. Am J Epidemiol 1996; 144: 207-213.
13. Zhao H, Spitz MR, Gwyn KM, Wu X. Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog 2002; 33: 99-104.
14. Yang Q, Khoury MJ, Sun F, Flanders WD. Case-only design to measure gene-gene interaction. Epidemiology 1999; 10: 167-170.
15. Cortessis V, Siegmund K, Chen Q, et al. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 2001; 61: 2381-2385.
16. Huang WY, Chatterjee N, Chanock S, et al. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005; 14: 152-157.
17. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE, Hunter DJ. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis 2004; 25: 1211-1218.
18. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 2001; 10: 875-882.
19. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 1999; 79: 168-171.
20. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002; 23: 1839-1849.
21. Robien K, Curtin K, Ulrich CM, et al. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 1350-1352.
22. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9: 3-28.
23. Slattery ML, Samowtiz W, Ma K, Murtaugh M, Sweeney C, Levin TR, et al. CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol 2004; 160: 842-852.
24. Fan C, Jin M, Chen K, Zhang Y, Zhang S, Liu B. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. BMC Cancer 2007; 7: 115.